ALB and myelodysplastic syndrome: In our cohort, several markers that have been evaluated in different studies, including neutrophil and monocyte counts, RDW, PDW, cholesterol, NLR, PLR, SII, NSII, creatinine, BUN, GFR, total bilirubin, LDH–ferritin ratio, albumin–NLR ratio, neutrophil/albumin ratio, PIV, FAR, and NPS, did not show a significant statistical impact on the prognosis of MDS.